InVivo Therapeutics Holdings Corp (NVIVQ)

[jrock777]

They have enough cash to make it through first q 2016. Also their market cap is way undervalued giving the potential for annual sales is over $500mm. Not to mention that there are only 70 places in America that do the majority of the spinal surveys showing that NVIV will be able to reach almost everyone who would administer the product in a very short time frame. We aren't looking to heal people who are paralyzed (even though that would be amazing) but looking to improve body function and quality of life. Primary point we are looking for once the first patient is enrolled (which isn't a question of if but when) is the safety of the device. If that comes back good (which all pre human study's came back with great safety indications) then we will see a share price pop significantly. We will also see the next enrollment with NVIV approaching the FDA to speed up the study by enrolling more then 1 patient at a time. This could be a game changer and the price is going into our short term favor. Imo